Skip to main content
. 2019 Mar 15;13(3):356–365. doi: 10.5009/gnl18242

Fig. 2.

Fig. 2

Preoperative MTV2.5 parameter and early systemic metastasis in resected pT3 pancreatic cancer. (A) Early systemic recurrence-free survival according to nodal metastasis. (B) Early systemic recurrence-free survival according to MTV2.5 value.

MTV, metabolic tumor volume; pT3, pathologic T3.